Who invested in Amber Therapeutics?
Amber Therapeutics's investors include New Enterprise Associates, 8VC and Oxford Science Enterprises.

United Kingdom · Venture startup
Funding summaryUpdated 26 Oct 2026
$102Mraised across 2 rounds since 2024, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
Amber Therapeutics filed one raise, $38M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Amber Therapeutics's own website: 4 founders, 2 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Amber Therapeutics's investors include New Enterprise Associates, 8VC and Oxford Science Enterprises.
Amber Therapeutics has raised $102M across 2 rounds since 2024. One round did not disclose an amount, so the total is a floor.
Amber Therapeutics's most recent round was a Venture in Mar 2026.
Amber Therapeutics's largest round on record is $102M (Series A), in Jun 2024.
Amber Therapeutics's first round on record, in Jun 2024, was backed by New Enterprise Associates, 8VC and Oxford Science Enterprises.
Amber Therapeutics's latest named round is a Venture, in Mar 2026.
Amber Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.